Us News

While every sectoral index closed in the red, IT and pharmaceutical stocks saw the biggest selling pressure.

The transaction will mark the largest U.S. market entry by a Korean non-life insurer, DB Insurance said.

The surge followed news that Medirom will deploy Sam Altman’s World ID Orb devices across its Re.Ra.Ku studios in Japan.

The BEA’s personal income and spending report for August is expected to show a 2.7% year-over-year increase in the personal consumption expenditure (PCE) index, up from the 2.6% rate in July.

Norwegian Air Shuttle also placed an order for 30 737 Max jets amid its efforts to expand services in Europe.

The European Commission cleared its Alzheimer’s drug Kisunla, adding another country to the company’s list where the once-monthly therapy is approved.

Intel CEO Lip-Bu Tan has reportedly spoken to Apple’s Tim Cook and TSMC’s C.C. Wei regarding a partnership or joint venture.

Bitcoin prices fell 2.2% to $109,279, Ethereum was down 1.9% to $3,931.77, and XRP prices declined 3.5% to $2.75, according to CoinGecko data.

The U.S. is reportedly investigating Waaree for evading antidumping and countervailing duties.

The new U.S. duty has already triggered a slide in major Asian pharma names, raising concerns about how Indian peers will react in the coming weeks.

The strategist noted that Nvidia, while accounting for 8% of the S&P 500's market capitalization weighting, contributes 7% of the S&P 500's earnings.

Earlier in the day, the Bitcoin miner had proposed a senior notes offering of $800 million to private institutional buyers, which resulted in a 17.5% decline in share price.

Commerce Secretary Howard Lutnick has reportedly discussed the plan with semiconductor industry executives, emphasizing to them the importance of the measure in ensuring economic security.

The Chinese EV maker is accelerating its global strategy through new partnerships and local production, aiming to strengthen its position in Europe.

The Nifty Pharma index was down 2.3% in early trade, with Natco, Biocon, and Laurus Labs among the top laggards.

The analyst noted that Syngene, Piramal Pharma, and Zydus Lifesciences may be better positioned, as their contract manufacturing models and biologics portfolios are less susceptible to the tariff impact.

This rumored move by the Mark Zuckerberg-led company is seen as an acknowledgement of the scaling issues the company has had with its AI technology.

Aquestive’s Anaphylm has drawn heightened investor attention after the CEO spotlighted it as the company’s first broad-market product.

Perpetua’s Stibnite project holds the biggest reserve of antimony in the U.S. The company began construction at the mine last week, having secured all the necessary permits.

The company plans to launch in the U.S. in early October, with a European launch expected in 2026.

Locomotive orders for Rites, a new battery plant investment by Exide, and JLR's cyber recovery are key things investors are eyeing today.

The BEA’s revised estimates showed 3.8% seasonally adjusted annual growth, above the 3.3% rate estimated, on average, by economists, with the real personal consumption expenditure upwardly revised to 2.5%.

The White House has not yet detailed how the tariffs will be rolled out, even as they overlap with a broader national security review of truck imports.

The infrared solutions provider’s loss widened primarily due to its acquisition of New Hampshire-based G5 Infrared, which it bought for $27 million in February.

Generic drugs remain exempt, while duties will apply to prescription, biologic, specialty and over-the-counter medicines.

All U.S. TikTok user data would be stored in a trusted, secure and purpose-built cloud environment in the U.S. run by Oracle.

Seaport analysts anticipate that the stock will be driven by follow-on investments and the potential for a "stop-gap solution" in the near term.

Since hitting a bottom of $79.75 on April 7 amid the sell-off triggered by Trump tariffs, the stock has added nearly 200%.

Hertz plans to use $300 million of the net proceeds from a notes offering to fund the partial redemption or repurchase of its outstanding senior notes, primarily due in 2026.

A record 289 million Lithium Americas shares traded hands on Wednesday, compared with its 200-day average trading volume of little over 7 million shares.

According to Jefferies analysts, Upstart's stock short interest jumped 606 basis points to 27.7% in August, the most significant jump among consumer finance companies.

Fund manager Louis Navellier noted that the market’s concentration has risen to a new high, with the top 10 stocks accounting for 41% of the S&P 500’s market capitalization.

The tablets will be manufactured at Lupin’s Nagpur facility and are indicated for adults and pediatric patients weighing at least 25 kg.

The investment bank’s analysts projected that the lost output at the second-largest copper mine will eliminate 525,000 metric tons of supply.

According to Koyfin data, the analysts’ consensus price target for the stock is $212.47, implying a 20% upside from its close on Wednesday.

Overall car registrations in the EU rose 5.3% as buyers continued shifting toward electrified vehicles, which made up more than 62% of the market.

The DMA was adopted by the EU in 2022 as a regulatory tool to regulate the power of the most prominent digital companies.

Energy trade will be a central focus of India-U.S. talks, alongside discussions on tariffs and market access.

Citi had to abandon a complete sale of its Mexican retail banking unit in 2023 after the former President, Andrés Manuel López Obrador, imposed strict restrictions on deal terms.

BlackBerry is widely expected to report second-quarter adjusted earnings per share of $0.01 and revenue of $122.03 million, according to the consensus provided by Koyfin.

The trial’s enrollment target has been raised to 339 patients, with completion expected by late 2026.

The focus has shifted to Tesla’s upcoming third-quarter deliveries, with some analysts projecting stronger-than-expected numbers.

Intel’s stock continued to rise as the company actively seeks outside investments to bolster its sagging fortunes.

Ivalue Infosolutions set to list on the mainboard today

The stock has already seen a fivefold increase this year, giving it a valuation of over $19 billion, more than three times the market capitalization of rival NuScale Power.

More than 500 lawsuits over Tylenol and autism were dismissed last year, but families are now appealing to the 2nd U.S. Circuit Court of Appeals, which is scheduled to hear arguments on Oct. 6.

The Switzerland-based company anticipates allocating a substantial portion of the proceeds from a stock offering to debt repayment.

Updated trial data showed its drug atebimetinib nearly doubled survival benchmarks in first-line pancreatic cancer, with the company planning a pivotal Phase 3 study by late 2025.

Intel’s stock has gained nearly 56% year-to-date as the company has made concerted efforts under new CEO Lip-Bu Tan to turn around its fortunes.

France’s economy ministry has reportedly scheduled an Oct. 7 inspection of Nissan’s European headquarters after requesting full 2024 accounting and payment records.